Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study
出版年份 2021 全文链接
标题
Encouraging the Development of New Antibiotics: Are Financial Incentives the Right Way Forward? A Systematic Review and Case Study
作者
关键词
-
出版物
Infection and Drug Resistance
Volume Volume 14, Issue -, Pages 415-434
出版商
Informa UK Limited
发表日期
2021-02-05
DOI
10.2147/idr.s287792
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Evaluating for-profit public benefit corporations as an additional structure for antibiotic development and commercialization
- (2020) Kevin Outterson et al. Translational Research
- Antibiotic prescription during the COVID-19 pandemic: A biphasic pattern
- (2020) Gabriela Abelenda-Alonso et al. INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY
- The Infectious Diseases Society of America’s 10 × ’20 Initiative (Ten New Systemic Antibacterial Agents FDA-approved by 2020): Is 20 × ’20 a Possibility?
- (2019) George H Talbot et al. CLINICAL INFECTIOUS DISEASES
- Global burden of latent multidrug-resistant tuberculosis: trends and estimates based on mathematical modelling
- (2019) Gwenan M Knight et al. LANCET INFECTIOUS DISEASES
- Health care providers’ perceptions regarding antimicrobial stewardship programs (AMS) implementation—facilitators and challenges: a cross-sectional study in the Eastern province of Saudi Arabia
- (2019) Mohamed A. Baraka et al. Annals of Clinical Microbiology and Antimicrobials
- The Economic Conundrum for Antibacterial Drugs
- (2019) David M. Shlaes ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Transferrable Market Exclusivity Extensions to Promote Antibiotic Development: An Economic Analysis
- (2019) Benjamin N Rome et al. CLINICAL INFECTIOUS DISEASES
- OUP accepted manuscript
- (2018) JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Diagnosis Confirmation Model: A Value-Based Pricing Model for Inpatient Novel Antibiotics
- (2018) Ka Lum et al. JOURNAL OF LAW MEDICINE & ETHICS
- A Grant Framework as a Push Incentive to Stimulate Research and Development of New Antibiotics
- (2018) Miloje Savic et al. JOURNAL OF LAW MEDICINE & ETHICS
- A Perspective on Incentives for Novel Inpatient Antibiotics: No One-Size-Fits-All
- (2018) Taimur Bhatti et al. JOURNAL OF LAW MEDICINE & ETHICS
- Implementation of a Market Entry Reward within the United States
- (2018) Gregory W. Daniel et al. JOURNAL OF LAW MEDICINE & ETHICS
- Simulating Market Entry Rewards for Antibiotics Development
- (2018) Christopher Okhravi et al. JOURNAL OF LAW MEDICINE & ETHICS
- Designing a Delinked Incentive for Critical Antibiotics: Lessons from Norway
- (2018) Christine Årdal et al. JOURNAL OF LAW MEDICINE & ETHICS
- Encouraging Sustainable Use of Antibiotics: A Commentary on the DRIVE-AB Recommended Innovation Incentives
- (2018) Chantal M. Morel et al. JOURNAL OF LAW MEDICINE & ETHICS
- Can public financing of the private sector defeat antimicrobial resistance?
- (2018) Jack E James JOURNAL OF PUBLIC HEALTH
- Global increase and geographic convergence in antibiotic consumption between 2000 and 2015
- (2018) Eili Y. Klein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- What are the economic barriers of antibiotic R&D and how can we overcome them?
- (2018) Mathew Renwick et al. Expert Opinion on Drug Discovery
- Antibiotic prescriptions to adults with acute respiratory tract infections by Italian general practitioners
- (2018) Aida Bianco et al. Infection and Drug Resistance
- Antibiotic resistance: a rundown of a global crisis
- (2018) Bilal Aslam et al. Infection and Drug Resistance
- Time for a change in how new antibiotics are reimbursed: Development of an insurance framework for funding new antibiotics based on a policy of risk mitigation
- (2017) Adrian Towse et al. HEALTH POLICY
- Addressing Antimicrobial Resistance and Stewardship
- (2017) Gregory W. Daniel et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Incentivising innovation in antibiotic drug discovery and development: progress, challenges and next steps
- (2017) Victoria L Simpkin et al. JOURNAL OF ANTIBIOTICS
- Regulatory Incentives for Antibiotic Drug Development: A Review of Recent Proposals
- (2016) Michael S. Sinha et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Economic Incentives for Antibacterial Drug Development: Literature Review and Considerations From the Transatlantic Task Force on Antimicrobial Resistance: Table 1.
- (2016) Kimberly Sciarretta et al. CLINICAL INFECTIOUS DISEASES
- Antibiotic reimbursement in a model delinked from sales: a benchmark-based worldwide approach
- (2016) John H Rex et al. LANCET INFECTIOUS DISEASES
- Past, Present, and Future of Antibacterial Economics: Increasing Bacterial Resistance, Limited Antibiotic Pipeline, and Societal Implications
- (2016) Katherine H. Luepke et al. PHARMACOTHERAPY
- A critical analysis of the review on antimicrobial resistance report and the infectious disease financing facility
- (2016) David M. Brogan et al. Globalization and Health
- Systems, not pills: The options market for antibiotics seeks to rejuvenate the antibiotic pipeline
- (2016) David M. Brogan et al. SOCIAL SCIENCE & MEDICINE
- Antibiotic resistance: what, why, where, when and how?
- (2015) N. Sabtu et al. BRITISH MEDICAL BULLETIN
- Inappropriate antibiotic prescription for respiratory tract indications: most prominent in adult patients
- (2015) Anne R J Dekker et al. FAMILY PRACTICE
- Repairing The Broken Market For Antibiotic Innovation
- (2015) Kevin Outterson et al. HEALTH AFFAIRS
- A systematic review and critical assessment of incentive strategies for discovery and development of novel antibiotics
- (2015) Matthew J Renwick et al. JOURNAL OF ANTIBIOTICS
- Antibiotic Resistance is a Tragedy of the Commons That Necessitates Global Cooperation
- (2015) Aidan Hollis et al. JOURNAL OF LAW MEDICINE & ETHICS
- Innovation of Novel Antibiotics: An Economic Perspective
- (2014) Michael R. McKellar et al. CLINICAL INFECTIOUS DISEASES
- New business models for antibiotic innovation
- (2014) Anthony D. So et al. UPSALA JOURNAL OF MEDICAL SCIENCES
- Incentives for new antibiotics: the Options Market for Antibiotics (OMA) model
- (2013) David M Brogan et al. Globalization and Health
- The Burden of Disease and the Changing Task of Medicine
- (2012) David S. Jones et al. NEW ENGLAND JOURNAL OF MEDICINE
- Antibacterial R&D incentives
- (2011) Ramanan Laxminarayan et al. NATURE REVIEWS DRUG DISCOVERY
- Fighting Antibiotic Resistance: Marrying New Financial Incentives To Meeting Public Health Goals
- (2010) Aaron S. Kesselheim et al. HEALTH AFFAIRS
- Antimicrobial sensitivity—A natural resource to be protected by a Pigouvian tax?
- (2010) Ivar Vågsholm et al. PREVENTIVE VETERINARY MEDICINE
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
- (2009) David Moher et al. PLOS MEDICINE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started